11-60339936-A-G
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6_Moderate
The NM_139249.4(MS4A6E):āc.425A>Gā(p.Gln142Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000731 in 1,613,700 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ).
Frequency
Consequence
NM_139249.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
MS4A6E | NM_139249.4 | c.425A>G | p.Gln142Arg | missense_variant | 4/5 | ENST00000684409.1 | |
MS4A6E | NR_170614.1 | n.593A>G | non_coding_transcript_exon_variant | 4/6 | |||
MS4A6E | NR_170616.1 | n.713A>G | non_coding_transcript_exon_variant | 5/6 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
MS4A6E | ENST00000684409.1 | c.425A>G | p.Gln142Arg | missense_variant | 4/5 | NM_139249.4 | P1 | ||
MS4A6E | ENST00000300182.8 | c.425A>G | p.Gln142Arg | missense_variant | 3/4 | 1 | P1 | ||
MS4A6E | ENST00000532756.1 | c.350A>G | p.Gln117Arg | missense_variant, NMD_transcript_variant | 3/5 | 4 |
Frequencies
GnomAD3 genomes AF: 0.000131 AC: 20AN: 152206Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000127 AC: 32AN: 251378Hom.: 0 AF XY: 0.000110 AC XY: 15AN XY: 135872
GnomAD4 exome AF: 0.0000671 AC: 98AN: 1461494Hom.: 0 Cov.: 31 AF XY: 0.0000564 AC XY: 41AN XY: 727086
GnomAD4 genome AF: 0.000131 AC: 20AN: 152206Hom.: 0 Cov.: 33 AF XY: 0.000175 AC XY: 13AN XY: 74360
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 13, 2021 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at